Cargando…
Proteolysis-targeting chimera against BCL-X(L) destroys tumor-infiltrating regulatory T cells
Regulatory T cells (Tregs) play an important role in maintaining immune homeostasis and, within tumors, their upregulation is common and promotes an immunosuppressive microenvironment. Therapeutic strategies that can eliminate Tregs in the tumor (i.e., therapies that do not run the risk of affecting...
Autores principales: | Kolb, Ryan, De, Umasankar, Khan, Sajid, Luo, Yuewan, Kim, Myung-Chul, Yu, Haijun, Wu, Chaoyan, Mo, Jiao, Zhang, Xin, Zhang, Peiyi, Zhang, Xuan, Borcherding, Nicholas, Koppel, Daniel, Fu, Yang-Xin, Zheng, Song Guo, Avram, Dorina, Zheng, Guangrong, Zhou, Daohong, Zhang, Weizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904819/ https://www.ncbi.nlm.nih.gov/pubmed/33627663 http://dx.doi.org/10.1038/s41467-021-21573-x |
Ejemplares similares
-
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
por: Khan, Sajid, et al.
Publicado: (2020) -
Assays and technologies for developing proteolysis targeting chimera degraders
por: Liu, Xingui, et al.
Publicado: (2020) -
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
por: He, Yonghan, et al.
Publicado: (2020) -
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
por: He, Yonghan, et al.
Publicado: (2020) -
PROTACs are effective in addressing the platelet toxicity associated with BCL-X(L) inhibitors
por: Zhang, Peiyi, et al.
Publicado: (2020)